» Articles » PMID: 37061661

Predicting Delirium in Older Non-intensive Care Unit Inpatients: Development and Validation of the DELIrium RisK Tool (DELIKT)

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2023 Apr 15
PMID 37061661
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Effective delirium prevention could benefit from automatic risk stratification of older inpatients using routinely collected clinical data.

Aim: Primary aim was to develop and validate a delirium prediction model (DELIKT) suitable for implementation in hospitals. Secondary aim was to select an anticholinergic burden scale as a predictor.

Method: We used one cohort for model development and another for validation with electronically available data collected within the first 24 h of admission. Included were patients aged ≥ 65, hospitalised ≥ 48 h with no stay > 24 h in an intensive care unit. Predictors, such as administrative and laboratory variables or an anticholinergic burden scale, were selected using a combination of feature selection filter method and forward/backward selection. The final model was based on logistic regression and the DELIKT was derived from the β-coefficients. We report the following performance measures: area under the curve, sensitivity, specificity and odds ratio.

Results: Both cohorts were similar and included over 10,000 patients each (mean age 77.6 ± 7.6 years) with 11% experiencing delirium. The model included nine variables: age, medical department, dementia, hemi-/paraplegia, catheterisation, potassium, creatinine, polypharmacy and the anticholinergic burden measured with the Clinician-rated Anticholinergic Scale (CrAS). The external validation yielded an AUC of 0.795. With a cut-off at 20 points in the DELIKT, we received a sensitivity of 79.7%, specificity of 62.3% and an odds ratio of 5.9 (95% CI 5.2, 6.7).

Conclusion: The DELIKT is a potentially automatic tool with predictors from standard care including the CrAS to identify patients at high risk for delirium.

Citing Articles

The Multidimensional Prognostic Index predicts incident delirium among hospitalized older patients with COVID-19: a multicenter prospective European study.

Morganti W, Custodero C, Veronese N, Topinkova E, Michalkova H, Polidori M Eur Geriatr Med. 2024; 15(4):961-969.

PMID: 38878221 PMC: 11377617. DOI: 10.1007/s41999-024-00987-y.


External validity of an automated delirium prediction model (DEMO) and comparison to the manual VMS-questions: a retrospective cohort study.

Mohmaed Ali M, Kalkman G, Wijers C, Fleuren H, Kramers C, de Wit H Int J Clin Pharm. 2023; 45(5):1128-1135.

PMID: 37713029 DOI: 10.1007/s11096-023-01641-6.

References
1.
Young J, Inouye S . Delirium in older people. BMJ. 2007; 334(7598):842-6. PMC: 1853193. DOI: 10.1136/bmj.39169.706574.AD. View

2.
Witlox J, Eurelings L, de Jonghe J, Kalisvaart K, Eikelenboom P, van Gool W . Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010; 304(4):443-51. DOI: 10.1001/jama.2010.1013. View

3.
Inouye S, van Dyck C, Alessi C, Balkin S, Siegal A, Horwitz R . Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990; 113(12):941-8. DOI: 10.7326/0003-4819-113-12-941. View

4.
Grossi C, Richardson K, Savva G, Fox C, Arthur A, Loke Y . Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II. BMC Geriatr. 2020; 20(1):267. PMC: 7393714. DOI: 10.1186/s12877-020-01657-x. View

5.
Collamati A, Martone A, Poscia A, Brandi V, Celi M, Marzetti E . Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res. 2015; 28(1):25-35. DOI: 10.1007/s40520-015-0359-7. View